RxDoctor Payments Data

Darlene Vargas Maldonado, MD

Urogynecology and Reconstructive Pelvic Surgery · San Juan, PRNPI 1063863710

Payments from drug & device makers

$5,752in general payments, 2019–2025

Across 24 payments — averaging $239.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C.$983
  • Axonics, Inc.$388
  • Medtronic$254
  • AbbVie$146
  • Boston Scientific$134
  • plus $175 from 2 others

What the payments were for

  • Travel & lodging$2,11537%
  • Food & beverage$1,13720%
  • Education$2,50043%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical10$3,673
Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C.2$983
Axonics, Inc.3$388
Medtronic4$254
AbbVie2$146
Boston Scientific1$134
Coloplast1$94
Merck1$81

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few urogynecology and reconstructive pelvic surgery providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$8,564
Medicare patients
29
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron23$13,134
Estradiol43$2,881

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in San Juan

Where these figures come from

Is this you, or does something look wrong? →